Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124934) titled 'A Study on the Pharmacokinetics and Key Influencing Factors of Rosuvastatin and Furosemide in Chinese Peritoneal Dialysis Patients' on May 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking University Third Hospital
Condition:
Chronic kidney disease
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-01
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299664
Disclaimer: Curated by HT Syndication....